Investors Alert: Join Immutep Class Action Now

Rosen Law Firm is alerting investors who bought Immutep Ltd. shares between March 2025 and March 2026 about a chance to join a class action lawsuit. The suit claims Immutep gave misleading information about the performance of a key drug trial, which allegedly harmed investors when the truth came out. If you want to be a lead plaintiff, you need to act by July 6, 2026. What does it mean for you? If you bought Immutep shares during that time, this could mean compensation for you without any upfront costs. It’s an opportunity to potentially recover some of your investment losses.